nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.421	0.535	CbGbCtD
Cyclopentolate—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.367	0.465	CbGbCtD
Cyclopentolate—BCHE—diaphragm—chronic obstructive pulmonary disease	0.0183	0.569	CbGeAlD
Cyclopentolate—Anterior uveitis—Prednisolone—chronic obstructive pulmonary disease	0.0172	0.102	CcSEcCtD
Cyclopentolate—Iridocyclitis—Prednisolone—chronic obstructive pulmonary disease	0.00989	0.0585	CcSEcCtD
Cyclopentolate—Intraocular pressure increased—Tiotropium—chronic obstructive pulmonary disease	0.00845	0.0499	CcSEcCtD
Cyclopentolate—Paralysis—Arformoterol—chronic obstructive pulmonary disease	0.00432	0.0255	CcSEcCtD
Cyclopentolate—Paralysis—Formoterol—chronic obstructive pulmonary disease	0.00432	0.0255	CcSEcCtD
Cyclopentolate—Intraocular pressure increased—Prednisolone—chronic obstructive pulmonary disease	0.00369	0.0218	CcSEcCtD
Cyclopentolate—Coma—Aminophylline—chronic obstructive pulmonary disease	0.0036	0.0213	CcSEcCtD
Cyclopentolate—Vasodilation—Salbutamol—chronic obstructive pulmonary disease	0.00322	0.019	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Salbutamol—chronic obstructive pulmonary disease	0.00322	0.019	CcSEcCtD
Cyclopentolate—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.0032	0.0189	CcSEcCtD
Cyclopentolate—Desvenlafaxine—SLC6A4—chronic obstructive pulmonary disease	0.00315	0.295	CrCbGaD
Cyclopentolate—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.00272	0.0161	CcSEcCtD
Cyclopentolate—Intraocular pressure increased—Prednisone—chronic obstructive pulmonary disease	0.00268	0.0159	CcSEcCtD
Cyclopentolate—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00256	0.0152	CcSEcCtD
Cyclopentolate—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00256	0.0151	CcSEcCtD
Cyclopentolate—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00247	0.0146	CcSEcCtD
Cyclopentolate—Gastroenteritis—Formoterol—chronic obstructive pulmonary disease	0.00246	0.0145	CcSEcCtD
Cyclopentolate—Gastroenteritis—Arformoterol—chronic obstructive pulmonary disease	0.00246	0.0145	CcSEcCtD
Cyclopentolate—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00242	0.0143	CcSEcCtD
Cyclopentolate—Gastroenteritis—Montelukast—chronic obstructive pulmonary disease	0.00241	0.0142	CcSEcCtD
Cyclopentolate—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00238	0.0141	CcSEcCtD
Cyclopentolate—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00232	0.0137	CcSEcCtD
Cyclopentolate—Gastroenteritis—Salbutamol—chronic obstructive pulmonary disease	0.00232	0.0137	CcSEcCtD
Cyclopentolate—CHRM1—trachea—chronic obstructive pulmonary disease	0.00211	0.0658	CbGeAlD
Cyclopentolate—BCHE—respiratory system—chronic obstructive pulmonary disease	0.00209	0.065	CbGeAlD
Cyclopentolate—CHRM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00206	0.0641	CbGeAlD
Cyclopentolate—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.0114	CcSEcCtD
Cyclopentolate—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00184	0.0109	CcSEcCtD
Cyclopentolate—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.0106	CcSEcCtD
Cyclopentolate—BCHE—bronchus—chronic obstructive pulmonary disease	0.00172	0.0535	CbGeAlD
Cyclopentolate—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.00168	0.0524	CbGeAlD
Cyclopentolate—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00164	0.00971	CcSEcCtD
Cyclopentolate—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00964	CcSEcCtD
Cyclopentolate—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00964	CcSEcCtD
Cyclopentolate—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00161	0.00954	CcSEcCtD
Cyclopentolate—Methylphenidate—SLC6A4—chronic obstructive pulmonary disease	0.00161	0.151	CrCbGaD
Cyclopentolate—Dexmethylphenidate—SLC6A4—chronic obstructive pulmonary disease	0.00161	0.151	CrCbGaD
Cyclopentolate—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00944	CcSEcCtD
Cyclopentolate—Venlafaxine—SLC6A4—chronic obstructive pulmonary disease	0.00159	0.149	CrCbGaD
Cyclopentolate—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00936	CcSEcCtD
Cyclopentolate—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.00936	CcSEcCtD
Cyclopentolate—BCHE—trachea—chronic obstructive pulmonary disease	0.00154	0.048	CbGeAlD
Cyclopentolate—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.0091	CcSEcCtD
Cyclopentolate—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.00905	CcSEcCtD
Cyclopentolate—CHRM1—lung—chronic obstructive pulmonary disease	0.00152	0.0473	CbGeAlD
Cyclopentolate—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00149	0.00882	CcSEcCtD
Cyclopentolate—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00868	CcSEcCtD
Cyclopentolate—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.00811	CcSEcCtD
Cyclopentolate—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00799	CcSEcCtD
Cyclopentolate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.00786	CcSEcCtD
Cyclopentolate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.00785	CcSEcCtD
Cyclopentolate—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.0078	CcSEcCtD
Cyclopentolate—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.00765	CcSEcCtD
Cyclopentolate—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00726	CcSEcCtD
Cyclopentolate—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00726	CcSEcCtD
Cyclopentolate—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00712	CcSEcCtD
Cyclopentolate—Agitation—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00712	CcSEcCtD
Cyclopentolate—Tremor—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00711	CcSEcCtD
Cyclopentolate—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00697	CcSEcCtD
Cyclopentolate—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00686	CcSEcCtD
Cyclopentolate—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00672	CcSEcCtD
Cyclopentolate—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00658	CcSEcCtD
Cyclopentolate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00657	CcSEcCtD
Cyclopentolate—BCHE—lung—chronic obstructive pulmonary disease	0.00111	0.0345	CbGeAlD
Cyclopentolate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00645	CcSEcCtD
Cyclopentolate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00645	CcSEcCtD
Cyclopentolate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00617	CcSEcCtD
Cyclopentolate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00617	CcSEcCtD
Cyclopentolate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00609	CcSEcCtD
Cyclopentolate—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00608	CcSEcCtD
Cyclopentolate—Atropine—CYP1A2—chronic obstructive pulmonary disease	0.00103	0.0964	CrCbGaD
Cyclopentolate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00606	CcSEcCtD
Cyclopentolate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000995	0.00588	CcSEcCtD
Cyclopentolate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000986	0.00583	CcSEcCtD
Cyclopentolate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000951	0.00562	CcSEcCtD
Cyclopentolate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000951	0.00562	CcSEcCtD
Cyclopentolate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000938	0.00554	CcSEcCtD
Cyclopentolate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000932	0.00551	CcSEcCtD
Cyclopentolate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000898	0.00531	CcSEcCtD
Cyclopentolate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000886	0.00524	CcSEcCtD
Cyclopentolate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000886	0.00523	CcSEcCtD
Cyclopentolate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000883	0.00522	CcSEcCtD
Cyclopentolate—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000837	0.00495	CcSEcCtD
Cyclopentolate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000836	0.00494	CcSEcCtD
Cyclopentolate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000835	0.00494	CcSEcCtD
Cyclopentolate—Pethidine—SLC6A4—chronic obstructive pulmonary disease	0.000815	0.0764	CrCbGaD
Cyclopentolate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000757	0.00447	CcSEcCtD
Cyclopentolate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000757	0.00447	CcSEcCtD
Cyclopentolate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000745	0.00441	CcSEcCtD
Cyclopentolate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000741	0.00438	CcSEcCtD
Cyclopentolate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000715	0.00422	CcSEcCtD
Cyclopentolate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00399	CcSEcCtD
Cyclopentolate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00399	CcSEcCtD
Cyclopentolate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000674	0.00398	CcSEcCtD
Cyclopentolate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.00398	CcSEcCtD
Cyclopentolate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000669	0.00396	CcSEcCtD
Cyclopentolate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000661	0.00391	CcSEcCtD
Cyclopentolate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00066	0.0039	CcSEcCtD
Cyclopentolate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000638	0.00377	CcSEcCtD
Cyclopentolate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000637	0.00377	CcSEcCtD
Cyclopentolate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000636	0.00376	CcSEcCtD
Cyclopentolate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000615	0.00364	CcSEcCtD
Cyclopentolate—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00059	0.00349	CcSEcCtD
Cyclopentolate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000566	0.00334	CcSEcCtD
Cyclopentolate—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00055	0.00325	CcSEcCtD
Cyclopentolate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000486	0.00287	CcSEcCtD
Cyclopentolate—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000474	0.0028	CcSEcCtD
Cyclopentolate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000464	0.00274	CcSEcCtD
Cyclopentolate—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000447	0.00264	CcSEcCtD
Cyclopentolate—Pethidine—ALB—chronic obstructive pulmonary disease	0.000428	0.0402	CrCbGaD
Cyclopentolate—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000428	0.0402	CrCbGaD
Cyclopentolate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000411	0.00243	CcSEcCtD
Cyclopentolate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.00216	CcSEcCtD
Cyclopentolate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.00216	CcSEcCtD
Cyclopentolate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000298	0.00176	CcSEcCtD
Cyclopentolate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00157	CcSEcCtD
Cyclopentolate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00157	CcSEcCtD
